| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| coltuximab ravtansine | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Lymphoma[MeSHID:D008223] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] |
NA | phase 2 | unknown |
| coltuximab ravtansine | b-lymphocyte antigen cd19 | biotech | NA | drugbank , DGIDB | Lymphoma[MeSHID:D008223] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] |
NA | investigational | unknown |
| click here to return to the previous page | ||||||||